Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02569437 · ClinicalTrials.gov registry record · Phase 2
Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps
A Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT02569437 is a Phase 2 study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 49 participants.
The verdict
NCT02569437, a Phase 2 study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
The Department of Otolaryngology at Mount Sinai is looking for adults with sinus disease with polyps, otherwise called chronic rhinosinusitis with nasal polyps (CRSwNP). Patients may be eligible to enroll in a study offering a cutting-edge therapy to help reduce symptoms and avoid surgery. The treatment combines an antibiotic (doxycycline) with oral steroids. Oral steroids are the mainstay of medical management for patients with CRSwNP. However, recent studies have shown that doxycycline helps improve symptoms as well by reducing inflammation and killing common bacteria that can cause symptoms. This study is the first to evaluate this combination regimen.
Interventions
- DRUG Doxycycline
- DRUG methylprednisolone
- DRUG sugar pill
- DRUG Flonase
- DRUG nasal saline spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02569437
The ClinicalTrials.gov registry entry for NCT02569437 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Doxycycline is the first listed.
NCT02569437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02569437 about?
NCT02569437 is a clinical study titled "Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps". The Department of Otolaryngology at Mount Sinai is looking for adults with sinus disease with polyps, otherwise called chronic rhinosinusitis with nasal polyps (CRSwNP). Patients may be eligible to enroll in a study offering a cutting-edge therapy to help reduce symptoms and avoid surgery. The treat...
What is the current status of trial NCT02569437?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2014-09. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02569437?
The interventions under investigation include: Doxycycline (DRUG), methylprednisolone (DRUG), sugar pill (DRUG), Flonase (DRUG), nasal saline spray (DRUG).
Who is sponsoring clinical trial NCT02569437?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.